Updated: Metro Region Companies Lead the Fight Against COVID-19

Johnson & Johnson: The Road to a Vaccine

This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine. Each week host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to bring an end to the deadly pandemic.

Pfizer: Pfizer advances battle against COVID-19 on multiple fronts

As outlined in Pfizer’s five-point plan, the company has been collaborating across the healthcare innovation ecosystem ranging from large pharmaceutical companies to the smallest of biotech companies, from government agencies to academic institutions to address the COVID-19 global health care crisis. Researchers and scientists have been relentlessly working to develop an investigational antiviral compound to treat SARS-CoV-2, which causes the current pandemic of coronavirus infections (COVID-19), a vaccine to prevent infection as well as evaluating other therapies that have scientific potential to help infected patients fight the virus. Click here to read more about Pfizer's battle against COVID-19.

Siemens: Siemens Healthineers to Expand SARS-CoV-2 Testing to Include a Total Antibody Test to Aid in the COVID-19 Pandemic

With a demonstrated sensitivity and specificity of more than 99 percent, the test is expected to exceed the stringent FDA quality guidelines. The test is expected to be available by late May on the company’s multiple laboratory-based high throughput analyzers with time to first result as short as 14 minutes. Planned expanded manufacturing production will accommodate more than 25 million tests per month in June and beyond. Click here to learn more about the Siemens Healthineers' Total Antibody Test.